Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02753686
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2016-04-20
Brief Title:
Treatment of Canadian Men and PrePeriPost-menopausal Women With ER Advanced Breast Cancer in the Real-World Setting With Hormone Therapy Targeted Therapy
Sponsor:
Organization:
Novartis
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
440
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 34550 |
Who Masked List: